VenBio Raises $288M for Second Venture Capital Fund

venbioVenBio, LLC, a bi-coastal healthcare venture capital firm, raised $288m for its second fund.

According to a regulatory filing with the SEC, venBio Global Strategic Fund II L.P. has a final target of $303m with $15m remained to be raised.

The document lists Corey Goodman and Robert Adelman as people related to the offering.

Founded in June 2009, venBio is a private equity and venture capital firm specializing in investments in early venture, mid venture, late venture, turnaround, Consolidation, Spin-outs, PIPEs, mezzanine financing, and bridge financing in life sciences sector.
The firm is based in San Francisco, California, with an additional office in New York.



Join the discussion